PHUONG UYEN LE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner ST PETERSBURG, FL NPI 1306507066
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$3,248.05
- Category: General Payments
- Program years: PY2022–2024
- Record count: 135
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,379.46 across 59 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,373.35 | 58 |
| Education | $6.11 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $251.73 | 9 |
| Lilly USA, LLC | $155.49 | 6 |
| PFIZER INC. | $111.19 | 5 |
| Gilead Sciences, Inc. | $108.90 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.62 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.92 | 3 |
| Astellas Pharma US Inc | $52.28 | 2 |
| E.R. Squibb & Sons, L.L.C. | $49.70 | 2 |
| Sumitomo Pharma America, Inc. | $48.89 | 2 |
| PharmaEssentia USA Corporation | $48.84 | 2 |
| Incyte Corporation | $45.12 | 2 |
| EMD Serono, Inc. | $42.73 | 2 |
| TAIHO ONCOLOGY, INC. | $38.34 | 2 |
| Rigel Pharmaceuticals, Inc. | $31.43 | 2 |
| Dendreon Pharmaceuticals LLC | $29.95 | 1 |
| Deciphera Pharmaceuticals Inc. | $24.42 | 1 |
| Blueprint Medicines Corporation | $22.77 | 1 |
| Merck Sharp & Dohme Corporation | $22.52 | 1 |
| Janssen Pharmaceuticals, Inc | $20.73 | 1 |
| ARRAY BIOPHARMA INC | $20.69 | 1 |
| Geron Corporation | $20.02 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.97 | 1 |
| Agios Pharmaceuticals, Inc. | $17.17 | 1 |
| SHIELD THERAPEUTICS INC | $15.56 | 1 |
| Alexion Pharmaceuticals, Inc. | $15.48 | 1 |
By program year
Records — PY2024 (59)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.